| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial
|
Tahami Monfared, Amir Abbas
|
|
|
12 |
3 |
p. 863-881
|
article
|
| 2 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study Investigating the Efficacy of a Whole Coffee Cherry Extract and Phosphatidylserine Formulation on Cognitive Performance of Healthy Adults with Self-Perceived Memory Problems
|
Doma, Katarina M.
|
|
|
12 |
3 |
p. 777-794
|
article
|
| 3 |
Causal Relationship Between Basal Metabolic Rate and Alzheimer’s Disease: A Bidirectional Two-sample Mendelian Randomization Study
|
Zou, Yuexiao
|
|
|
12 |
3 |
p. 763-776
|
article
|
| 4 |
Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer’s Disease
|
Morin, Peter J.
|
|
|
12 |
3 |
p. 721-726
|
article
|
| 5 |
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
|
Chen, Yu-Luan
|
|
|
12 |
3 |
p. 815-832
|
article
|
| 6 |
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis in the United States
|
Kantor, Daniel
|
|
|
12 |
3 |
p. 849-861
|
article
|
| 7 |
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
|
Abdelnour, Carla
|
|
|
12 |
3 |
p. 727-749
|
article
|
| 8 |
Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease
|
Saposnik, Gustavo
|
|
|
12 |
3 |
p. 995-1006
|
article
|
| 9 |
Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
|
Śmiałek, Dominika
|
|
|
12 |
3 |
p. 931-946
|
article
|
| 10 |
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
|
Amezcua, Lilyana
|
|
|
12 |
3 |
p. 883-897
|
article
|
| 11 |
Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
|
Tahami Monfared, Amir Abbas
|
|
|
12 |
3 |
p. 795-814
|
article
|
| 12 |
Familial Mediterranean Fever and Transverse Myelitis: A Causal Relation?
|
Motahharynia, Ali
|
|
|
12 |
3 |
p. 1007-1013
|
article
|
| 13 |
Frameless Robot-Assisted Asleep Centromedian Thalamic Nucleus Deep Brain Stimulation Surgery in Patients with Drug-Resistant Epilepsy: Technical Description and Short-Term Clinical Results
|
Wang, Changquan
|
|
|
12 |
3 |
p. 977-993
|
article
|
| 14 |
Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis
|
Zhang, Yao-Chen
|
|
|
12 |
3 |
p. 751-762
|
article
|
| 15 |
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis
|
Perumal, Jai
|
|
|
12 |
3 |
p. 833-848
|
article
|
| 16 |
Optimizing The Timing of Stereotactic Minimally Invasive Drainage for Hypertensive Intracerebral Hemorrhage
|
Li, Jingchen
|
|
|
12 |
3 |
p. 919-930
|
article
|
| 17 |
Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis
|
Roman, Cortnee
|
|
|
12 |
3 |
p. 711-719
|
article
|
| 18 |
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
|
Liang, Beibei
|
|
|
12 |
3 |
p. 947-959
|
article
|
| 19 |
The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy
|
Feng, Yijie
|
|
|
12 |
3 |
p. 961-976
|
article
|
| 20 |
The Migraine Stigma Kaleidoscope View
|
Gross, Elena
|
|
|
12 |
3 |
p. 703-709
|
article
|
| 21 |
Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data
|
Tahami Monfared, Amir Abbas
|
|
|
12 |
3 |
p. 899-918
|
article
|
Journal description